Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled Ingredients

Nicotine and Tobacco Research

Volumn 21, Issue 3, 2019, Pages 314-322

  Landmesser, Anne ^a,b   Scherer, Max ^a   Pluym, Nikola ^a   Sarkar, Mohamadi ^c   Edmiston, Jeffery ^c   Niessner, Reinhard ^b   Scherer, Gerhard ^a  

^a ABF Analytisch Biologisches Forschungslabor GmbH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Altria Client Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; COTININE; EPOXIDE; GLYCEROL; NICOTINE; PROPYLENE GLYCOL; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CHEMICAL COMPOSITION; CIGARETTE SMOKING; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; MALE; MEASUREMENT ACCURACY; MIDDLE AGED; NORMAL HUMAN; PRIORITY JOURNAL; PROOF OF CONCEPT; QUANTITATIVE ANALYSIS; SALIVA ANALYSIS; URINALYSIS; URINE LEVEL; VAPING; VAPOR; VOLUNTEER; YOUNG ADULT; BLOOD; ELECTRONIC CIGARETTE; EPIDEMIOLOGY; GERMANY; RANDOMIZED CONTROLLED TRIAL; SMOKING; TOBACCO;

ADULT; BIOMARKERS; ELECTRONIC NICOTINE DELIVERY SYSTEMS; GERMANY; HUMANS; MALE; MIDDLE AGED; NICOTINE; SMOKERS; SMOKING; TOBACCO PRODUCTS; VAPING; YOUNG ADULT;

EID: 85062059498     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nty204     Document Type: Article

References (51)

1. Adkison SE, O'Connor RJ, Bansal-Travers M, et al. Electronic nicotine delivery systems: International Tobacco Control Four-Country Survey. Am J Prev Med. 2013;44(3):207-215.
2. Drope J, Cahn Z, Kennedy R, et al. Key issues surrounding the health impacts of electronic nicotine delivery systems (ENDS) and other sources of nicotine. CA Cancer J Clin. 2017;67(6):449-471.
3. Jankowski M, Brożek G, Lawson J, Skoczyński S, Zejda JE. E-smoking: emerging public health problem? Int J Occup Med Environ Health. 2017;30(3):329-344.
4. Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction. 2014;109(11):1801-1810.
5. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. DNA Repair (Amst). 2014;5(2):1-11.
6. DeVito EE, Krishnan-Sarin S. E-cigarettes: impact of e-liquid components and device characteristics on nicotine exposure. Curr Neuropharmacol. 2018;16(4):438-459.
7. Hahn J, Monakhova YB, Hengen J, et al. Electronic cigarettes: overview of chemical composition and exposure estimation. Tob Induc Dis. 2014;12(1):23.
8. US Department of Health and Human Services. E-Cigarette Use Among Youth and Young Adults. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2016.
9. Pisinger C, Døssing M. A systematic review of health effects of electronic cigarettes. Prev Med. 2014;69:248-260.
10. Famele M, Palmisani J, Ferranti C, et al. Liquid chromatography with tandem mass spectrometry method for the determination of nicotine and minor tobacco alkaloids in electronic cigarette refill liquids and secondhand generated aerosol. J Sep Sci. 2017;40(5):1049-1056.
11. Famele M, Ferranti C, Abenavoli C, Palleschi L, Mancinelli R, Draisci R. The chemical components of electronic cigarette cartridges and refill fluids: review of analytical methods. Nicotine Tob Res. 2015;17(3):271-279.
12. Farsalinos KE, Kistler KA, Gillman G, Voudris V. Evaluation of electronic cigarette liquids and aerosol for the presence of selected inhalation toxins. Nicotine Tob Res. 2015;17(2):168-174.
13. Margham J, McAdam K, Forster M, et al. Chemical composition of aerosol from an e-cigarette: a quantitative comparison with cigarette smoke. Chem Res Toxicol. 2016;29(10):1662-1678.
14. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities' regulation. Int J Environ Res Public Health. 2013;10(6):2500-2514.
15. Farsalinos KE, Romagna G, Voudris V. Factors associated with dual use of tobacco and electronic cigarettes: a case control study. Int J Drug Policy. 2015;26(6):595-600.
16. Lee YO, Nonnemaker JM, Bradfield B, Hensel EC, Robinson RJ. Examining daily electronic cigarette puff topography among established and non-established cigarette smokers in their natural environment. Nicotine Tob Res. 2018;20(10):1283-1288.
17. Hiler M, Breland A, Spindle T, et al. Electronic cigarette user plasma nicotine concentration, puff topography, heart rate, and subjective effects: Influence of liquid nicotine concentration and user experience. Exp Clin Psychopharmacol. 2017;25(5):380-392.
18. Farsalinos K, Poulas K, Voudris V. Changes in puffing topography and nicotine consumption depending on the power setting of electronic cigarettes. Nicotine Tob Res. 2018;20(8):993-997.
19. Cunningham A, Slayford S, Vas C, Gee J, Costigan S, Prasad K. Development, validation and application of a device to measure e-cigarette users' puffing topography. Sci Rep. 2016;6:35071.
20. Robinson RJ, Hensel EC, Roundtree KA, Difrancesco AG, Nonnemaker JM, Lee YO. Week long topography study of young adults using electronic cigarettes in their natural environment. PLoS One. 2016;11(10):e0164038.
21. Spindle TR, Hiler MM, Breland AB, Karaoghlanian NV, Shihadeh AL, Eissenberg T. The influence of a mouthpiece-based topography measurement device on electronic cigarette user's plasma nicotine concentration, heart rate, and subjective effects under directed and ad libitum use conditions. Nicotine Tob Res. 2017;19(4):469-476.
22. Wittmann C. Metabolic flux analysis using mass spectrometry. Adv Biochem Eng/Biotechnol. 2002;74:39-64.
23. Evershed RP, Crossman ZM, Bull ID, et al. 13C-Labelling of lipids to investigate microbial communities in the environment. Curr Opin Biotechnol. 2006;17(1):72-82.
24. Darmaun D, Mauras N. Use of stable isotopes to assess protein and amino acid metabolism in children and adolescents: a brief review. Horm Res. 2005;64(Suppl 3):32-37.
25. Bequette BJ, Sunny NE, El-Kadi SW, Owens SL. Application of stable isotopes and mass isotopomer distribution analysis to the study of intermediary metabolism of nutrients. J Anim Sci. 2006;84 (Suppl):E50-E59.
26. Melvin MS, Avery KC, Ballentine RM, Gardner WP, Wagner KA. Thermal Degradation Studies of Electronic Cigarette Liquids Part 2: Development of a Model Reaction System Used to Study α-Dicarbonyl Formation. CORESTA SSPT 2017. Kitzbuehel, Austria; 2017.
27. Pankow JF, Kim K, McWhirter KJ, et al. Benzene formation in electronic cigarettes. PLoS One. 2017;12(3):e0173055.
28. Godin JP, Ross AB, Rezzi S, et al. Isotopomics: a top-down systems biology approach for understanding dynamic metabolism in rats using [1,2-(13) C(2)] acetate. Anal Chem. 2010;82(2):646-653.
29. Guillory J, Kim A, Murphy J, Bradfield B, Nonnemaker J, Hsieh Y. Comparing Twitter and online panels for survey recruitment of e-cigarette users and smokers. J Med Internet Res. 2016;18(11):e288.
30. Robinson RJ, Hensel EC, Morabito PN, Roundtree KA. Electronic cigarette topography in the natural environment. PLoS One. 2015;10(6):e0129296.
31. Etter JF. Explaining the effects of electronic cigarettes on craving for tobacco in recent quitters. Drug Alcohol Depend. 2015;3(14):02010-02019.
32. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993;694:72-77.
33. Sagel SD, Chmiel JF, Konstan MW. Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc. 2007;4(4):406-417.
34. Scherer G, Jarczyk L, Heller WD, Biber A, Neurath GB, Adlkofer F. Pharmacokinetics of nicotine, cotinine, and 3'-hydroxycotinine in cigarette smokers. Klin Wochenschr. 1988;66(Suppl 11):5-11.
35. St Helen G, Ross KC, Dempsey DA, Havel CM, Jacob P III, Benowitz NL. Nicotine delivery and vaping behavior during ad libitum e-cigarette access. Tob Regul Sci. 2016;2(4):363-376.
36. Wagener TL, Floyd EL, Stepanov I, et al. Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tob Control. 2017;26(e1):e23-e28.
37. Marsot A, Simon N. Nicotine and cotinine levels with electronic cigarette: a review. Int J Toxicol. 2016;35(2):179-185.
38. Lopez AA, Hiler MM, Soule EK, et al. Effects of electronic cigarette liquid nicotine concentration on plasma nicotine and puff topography in tobacco cigarette smokers: a preliminary report. Nicotine Tob Res. 2016;18(5):720-723.
39. Farsalinos KE, Spyrou A, Stefopoulos C, et al. Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers). Sci Rep. 2015;5:13506.
40. de Mendizabal NV, Jones DR, Jahn A, Bies RR, Brown JW. Nicotine and cotinine exposure from electronic cigarettes: a population approach. Clin Pharmacokinet. 2015;54(6):615-626.
41. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res. 2013;15(1):267-270.
42. St Charles FK, McAughey J, Shepperd CJ. Methodologies for the quantitative estimation of toxicant dose to cigarette smokers using physical, chemical and bioanalytical data. Inhal Toxicol. 2013;25(7):383-397.
43. Schroeder MJ, Hoffman AC. Electronic cigarettes and nicotine clinical pharmacology. Tob Control. 2014;23(Suppl 2):ii30-35.
44. Laugesen M. Nicotine and toxicant yield ratings of electronic cigarette brands in New Zealand. N Z Med J. 2015;128(1411):77-82.
45. Piller M, Gilch G, Scherer G, Scherer M. Simple, fast and sensitive LC-MS/ MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolites. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;951-952 (1 March 2014):7-15.
46. Levi M, Dempsey DA, Benowitz NL, Sheiner LB. Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application. J Pharmacokinet Pharmacodyn. 2007;34(1):23-34.
47. Yu DK, Elmquist WF, Sawchuk RJ. Pharmacokinetics of propylene glycol in humans during multiple dosing regimens. J Pharm Sci. 1985;74(8):876-879.
48. Speth PA, Vree TB, Neilen NF, et al. Propylene glycol pharmacokinet-ics and effects after intravenous infusion in humans. Ther Drug Monit. 1987;9(3):255-258.
49. LaKind JS, McKenna EA, Hubner RP, Tardiff RG. A review of the comparative mammalian toxicity of ethylene glycol and propylene glycol. Crit Rev Toxicol. 1999;29(4):331-365.
50. Phillips B, Titz B, Kogel U, et al. Toxicity of the main electronic cigarette components, propylene glycol, glycerin, and nicotine, in Sprague-Dawley rats in a 90-day OECD inhalation study complemented by molecular endpoints. Food Chem Toxicol. 2017;109(Pt 1):315-332.
51. Nelson JL, Harmon ME, Robergs RA. Identifying plasma glycerol concentration associated with urinary glycerol excretion in trained humans. J Anal Toxicol. 2011;35(9):617-623.